醫療保健

Kindeva Life Sciences Facility - Woodbury

11200 Hudson Rd Woodbury, Minnesota 美國 55129
叫價 查詢售價
面積
淨營運收入 淨營運收入 不適用
投資回報率 不適用

文件

我接受保密協議
歡迎建立您的 Investor Centre 帳戶,儲存您的搜尋結果及設定投資偏好,儲存及分享投資機遇,查閱獨家文件及更多。如有疑問,請查閱<a href="#">「常見問題」。</a> 如想進入交易室,請提交申請予我們的物業顧問團隊批核。申請獲批核後,我們將會以電郵通知閣下。如有疑問,請查閱<a href="#">「常見問題」。</a> 您必須先簽署保密協議才可查閱上載於交易室內的專用文件。一經簽署保密協議,表示您同意及確認不會洩露及公開有關本物業的敏感資料。如有疑問,請查閱「常見問題」。
我接受保密協議 我接受保密協議
歡迎建立您的 Investor Centre 帳戶,儲存您的搜尋結果及設定投資偏好,儲存及分享投資機遇,查閱獨家文件及更多。如有疑問,請查閱<a href="#">「常見問題」。</a> 您必須先簽署保密協議才可查閱上載於交易室內的專用文件。一經簽署保密協議,表示您同意及確認不會洩露及公開有關本物業的敏感資料。如有疑問,請查閱「常見問題」。

特點

落成年份 2021
建築面積 總收入
入住 100.0 %
要約邀請 2022-06-30

物業簡介

Jones Lang LaSalle, Inc. (“JLL”) Capital Markets is pleased to present the opportunity to acquire the fee-simple interest in Kindeva Drug Delivery Global Headquarters, located at 11200 Hudson Rd, Woodbury, Minnesota (the “Subject” or “Property”). The Property is a 137,811 square foot, Class A, new construction build-to-suit life science current good manufacturing practice (“cGMP”) and research & development (“R&D”) facility leased to Kindeva Drug Delivery (“Kindeva”) which also serves as its global headquarters. Kindeva has over 14 years of term remaining on its original lease which commenced upon completion of the Property in September 2021.

Kindeva is a contract development and manufacturing organization (“CDMO”) with over 100 years of history in the space. In 2020, Kindeva was established when 3M spun out its drug delivery business in a $650 million transaction whereby Altaris Capital Partners (“Altaris”) acquired the business and 3M retained a 17% stake in the new company. As a CDMO, Kindeva is hired by pharmaceutical companies to develop different methods of delivery for products and subsequently assist in the manufacturing of the final product.

The Property is positioned in the highly desirable city of Woodbury, an affluent, high-growth suburb of Minneapolis. Woodbury’s average household income and population growth rate both greatly exceed the national averages, with income levels and five year population growth 59% and 55% higher than the national averages, respectively. Along with the favorable demographics in Woodbury, the Minneapolis MSA is quickly becoming one of the nation’s foremost med-tech and life science innovation centers. Minneapolis has seen a massive influx of investment and demand for life science, driven by record venture capital and National Institutes of Health (“NIH”) funding of $3.7 billion from 2019 through 2021. This has solidified Minnesota as #1 in med-tech jobs per capita and #2 for medical device and manufacturing firms and employees.

投資亮點

  • State-of-the-art, Mission-Critical Life Sciences Facility
    • Mission-critical global Kindeva headquarters includes distribution, manufacturing (“cGMP”), and research and development. Kindeva has invested over $10 million, or $73 PSF, of its own capital into the space, showing its strong commitment to the location
    • Property allows for the ability to expand to help accommodate future growth
  • Industry-Leading Tenant
    • Established $300 million+ revenue global company in high-growth disposable drug delivery sector with recent buyout by Altaris and 17% retained ownership by 3M (Moody’s: A1)
    • The CDMO market has grown 33% since 2020 and forecasted to continue rapid growth
  • Desirable, High Growth Location
    • The City of Woodbury has a significant amount of construction projects underway as well as planned development in the immediate future, including a 514,000 square foot industrial facility leased by the world’s largest e-commerce company, over 1,000 multifamily and senior housing units, and many more residential and commercial projects
  • Quintessential Life Science Investment
    • ​​​​​​​Kindeva Drug Delivery is one of the few core life science offerings in the Minneapolis-St. Paul market and features a growing tenant with a long-term lease
  • Robust Minneapolis-St. Paul Economy
  • ​​​​​​​Top 10 metro in the United States in total life science employment


Class A, Global HQ, and Life Science cGMP and R&D

11200 Hudson Rd, Woodbury, MN 55129

137,811 total square feet

43,565 (32%) square feet R&D + cGMP

2 floors & mezzanine level

33-36+ feet clear height

100% occupancy

14+ years remaining lease term

2.5% annual rent increases

$10+ million tenant investment

Last Updated Date: 08 Jun 2022

提交要求時出現錯誤。請重試或在此提交查

 

私隱通知

仲量聯行(包括附屬公司及聯屬公司)是全球著名的房地產及投資管理服務供應商。我們認真履行保障向我們提供的個人資料的責任。

一般而言,我們向你收集的個人資料僅用於處理你的查詢。

我們致力以適當的安全級別保障你的個人資料,並在法律允許的商業或法律原因下保留我們所需的時間。其後我們將安全及穩妥地刪除有關資料。有關仲量聯行如何處理你的個人資料的更多詳情,請查閱我們的私隱聲明

Last Updated Date: 08 Jun 2022

如有疑問,請查閱「常見問題」。

JLL 融資顧問服務

JLL可助您管理投資組合及籌集資金。
請即以電郵聯絡我們,瞭解我們如何助您實現願景。